21 CFR 520.82a

§ 520.82a Aminopropazine.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 520.82a, § 520.82a Aminopropazine, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87067
Permanent ID: ys:prov:87067@1
SHA-256: 036ec664e95cac327b623bc2f9178b39a1f4e36ec200e52e9784fba6487a6b1e

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each tablet contains aminopropazine fumarate equivalent to 25 percent aminopropazine base. (b) Sponsor. See No. 000061 in § 510.600(c) of this chapter. (c) Conditions of use in dogs and cats—(1) Amount. Administer orally at a dosage of 1 to 2 milligrams per pound of body weight, repeated every 12 hours as indicated. (2) Indications for use. For reducing excessive smooth muscle contractions, such as occur in urethral spasms associated with urolithiasis. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.